Introducing the OcuCheck™ Biosensor
The OcuCheck is a revolutionary point of care device designed to provide unparalled precision in tear fluid analysis.
​
The core technology of our sensor allows for superior data analytics to guide disease diagnosis and management.
Our platform technology delivers a quantitative, immediate result.
​
qUANTITATIVE dIAGNOSTICS
A Quantitative Measurement Tear Fluid Biomarkers Such As MMP-9 And Lacritin
pERSONALIZED treatment solutions
An Objective Measurement Can Be Used To Standardize And Classify Different Forms Of Dry Eye Disease.
INNOVATIVE PLATFORM TECHNOLOGY
Multi-Platform Technology Can Pivot To Detect Biomarkers For Systemic Disease
ABOUT US
ADVANCING TEAR FLUID ANALYTICS
Our company is dedicated to translational research initiatives that will advance diagnostics and evaluation of eye and systemic disease. Our primary focus is to provide an objective measurement of tear fluid biomarkers to standardize treatment solutions not only for dry eye but for systemic disease. We are an innovative tear fluid analytic company enabling detection of hard to diagnose diseases by collecting and analyzing tear fluid in a non-invasive way.
OUR FOCUS
IMPROVING ACCESS TO CARE
Working together to seamlessly translate innovations from the laboratory to clinical practice, elevating personalized medicine through the integration of cutting-edge technology into clinical settings.
​
Our current research and development efforts are centered on expanding the capabilities of the OcuCheck Biosensor to screen, analyze, and manage a range of eye and systemic disease.
INNOVATION
The OcuCheck is a point-of-care device that uses a specialized electrochemical sensor with proprietary coatings to measure specific biomarkers present in the tear fluid. Currently, the OcuCheck is the only device that can simultaneously measure MMP-9 and tear film osmolarity in one device. It is also one of the most accurate devices for quantitative measurement of MMP-9.
​
The OcuCheck device is lightweight, portable, and durable so that it can be used outside of a clinical setting.
NEWSROOM
